(VIANEWS) – Bebe stores (BEBE), ConAgra Foods (CAG), Amgen (AMGN) are the highest payout ratio stocks on this list.
We have gathered information regarding stocks with the highest payout ratio at the moment. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. Bebe stores (BEBE)
776.29% Payout Ratio
bebe stores, inc. does not have significant operations. Previously, it was engaged in the design, development, and production of women's apparel and accessories. The company marketed its products under the bebe and BEBE SPORT brand names through its retail stores; bebe.com, an online store; and 39 bebe outlet stores. It also offered its products through its 82 international licensee operated stores in 22 countries. bebe stores, inc. was founded in 1976 and is headquartered in Brisbane, California.
Earnings Per Share
As for profitability, Bebe stores has a trailing twelve months EPS of $0.06.
PE Ratio
Bebe stores has a trailing twelve months price to earnings ratio of 45.33. Meaning, the purchaser of the share is investing $45.33 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -43.18%.
2. ConAgra Foods (CAG)
77.99% Payout Ratio
Conagra Brands, Inc., together with its subsidiaries, operates as a consumer packaged goods food company in North America. The company operates in four segments: Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice. The Grocery & Snacks segment primarily offers shelf stable food products through various retail channels in the United States. The Refrigerated & Frozen segment provides temperature-controlled food products through various retail channels in the United States. The International segment offers food products in various temperature states through retail and foodservice channels outside of the United States. The Foodservice segment offers branded and customized food products, including meals, entrees, sauces, and various custom-manufactured culinary products packaged for restaurants and other foodservice establishments in the United States. The company sells its products under the Birds Eye, Duncan Hines, Healthy Choice, Marie Callender's, Reddi-wip, Slim Jim, Angie's BOOMCHICKAPOP, Duke's, Earth Balance, Gardein, and Frontera brands. The company was formerly known as ConAgra Foods, Inc. and changed its name to Conagra Brands, Inc. in November 2016. Conagra Brands, Inc. was founded in 1919 and is headquartered in Chicago, Illinois.
Earnings Per Share
As for profitability, ConAgra Foods has a trailing twelve months EPS of $1.42.
PE Ratio
ConAgra Foods has a trailing twelve months price to earnings ratio of 23.48. Meaning, the purchaser of the share is investing $23.48 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.05%.
Yearly Top and Bottom Value
ConAgra Foods’s stock is valued at $33.33 at 14:23 EST, way under its 52-week high of $41.30 and higher than its 52-week low of $32.18.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Apr 26, 2023, the estimated forward annual dividend rate is 1.32 and the estimated forward annual dividend yield is 4%.
3. Amgen (AMGN)
54.04% Payout Ratio
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
Earnings Per Share
As for profitability, Amgen has a trailing twelve months EPS of $14.72.
PE Ratio
Amgen has a trailing twelve months price to earnings ratio of 15.97. Meaning, the purchaser of the share is investing $15.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 252.78%.
Sales Growth
Amgen’s sales growth is 1.2% for the current quarter and 2.3% for the next.
Yearly Top and Bottom Value
Amgen’s stock is valued at $235.12 at 14:23 EST, way under its 52-week high of $296.67 and way higher than its 52-week low of $211.71.
Revenue Growth
Year-on-year quarterly revenue growth declined by 2.1%, now sitting on 26.19B for the twelve trailing months.
4. The First of Long Island Corporation (FLIC)
45.86% Payout Ratio
The First of Long Island Corporation operates as the holding company for The First National Bank of Long Island that provides financial services to small and medium-sized businesses, professionals, consumers, municipalities, and other organizations. The company offers business and small business checking, personal checking, negotiable order of withdrawal, interest on lawyer, escrow service, rent security, personal and nonpersonal money market, savings, time deposit, holiday club, and individual retirement accounts. It also provides commercial and residential mortgage, commercial and industrial, small business credit scored, Small Business Administration, construction and land development, consumer, and home equity lines of credit/loans, as well as commercial and standby letters of credit; debit or credit cards; and overdraft facilities. In addition, the company offers life insurance, trust, estate and custody, retail investment, bill payment, lockbox, ACH, safe deposit box rental, wire transfer, money order, checkbook printing, check, ATM, and online and mobile banking services, as well as investment securities, management, and advisory services. It operates 40 branches, including 17 branches in Nassau, 15 in Suffolk, 5 in Queens, 2 in Brooklyn, and 1 in Manhattan. The company was founded in 1927 and is headquartered in Glen Head, New York.
Earnings Per Share
As for profitability, The First of Long Island Corporation has a trailing twelve months EPS of $1.81.
PE Ratio
The First of Long Island Corporation has a trailing twelve months price to earnings ratio of 6.83. Meaning, the purchaser of the share is investing $6.83 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.88%.
Volume
Today’s last reported volume for The First of Long Island Corporation is 106029 which is 38.05% below its average volume of 171155.
5. Badger Meter (BMI)
36.01% Payout Ratio
Badger Meter, Inc. manufactures and markets flow measurement, quality, control, and communication solutions in the United States, Asia, Canada, Europe, Mexico, the Middle East, and internationally. It offers mechanical or static water meters, and related radio and software technologies and services to municipal water utilities. The company also provides flow instrumentation products, including meters, valves, and other sensing instruments to measure and control fluids going through a pipe or pipeline, including water, air, steam, oil, and other liquids and gases to original equipment manufacturers as the primary flow measurement device within a product or system, as well as through manufacturers' representatives. Its flow instrumentation products are used in water/wastewater, heating, ventilating and air conditioning, and corporate sustainability markets. In addition, the company offers ORION Migratable for automatic meter reading; ORION (SE) for traditional fixed network applications; and ORION Cellular for infrastructure-free fixed network meter reading solution, as well as BEACON advanced metering analytics, a secure cloud-hosted software suite that establishes alerts for specific conditions and allows consumer engagement tools that permit end water customers to view and manage their water usage activity. It also serves water utilities, industrial, and other industries. The company sells its products directly, as well as through resellers and representatives. Badger Meter, Inc. was founded in 1905 and is headquartered in Milwaukee, Wisconsin.
Earnings Per Share
As for profitability, Badger Meter has a trailing twelve months EPS of $2.42.
PE Ratio
Badger Meter has a trailing twelve months price to earnings ratio of 59.38. Meaning, the purchaser of the share is investing $59.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.49%.
Moving Average
Badger Meter’s value is higher than its 50-day moving average of $142.33 and way above its 200-day moving average of $120.17.
Previous days news about Badger Meter (BMI)
- According to Zacks on Tuesday, 18 July, "Some better-ranked stocks in the broader technology space are InterDigital (IDCC Quick QuoteIDCC – Free Report) , Badger Meter (BMI Quick QuoteBMI – Free Report) and Woodward (WWD Quick QuoteWWD – Free Report) . ", "InterDigital and Woodward sport a Zacks Rank #1 (Strong Buy), while Badger Meter carries a Zacks Rank #2 (Buy). "
- According to Zacks on Wednesday, 19 July, "Some better-ranked stocks in the broader technology space are InterDigital (IDCC Quick QuoteIDCC – Free Report) , Badger Meter (BMI Quick QuoteBMI – Free Report) and Woodward (WWD Quick QuoteWWD – Free Report) . ", "InterDigital sports a Zacks Rank #1 (Strong Buy), while Badger Meter and Woodward carry a Zacks Rank #2 (Buy). "
6. Kayne Anderson MLP Investment Company (KYN)
30.88% Payout Ratio
Kayne Anderson MLP Investment Company is a closed ended equity mutual fund launched and managed by KA Fund Advisors, LLC. It is co-managed by Kayne Anderson Capital Advisors, L.P. The fund invests in the public equity markets of the United States. It invests in stocks of companies operating in the energy sector. The fund primarily invests in energy-related master limited partnerships. Kayne Anderson MLP Investment Company was formed on June 4, 2004 and is domiciled in the United States.
Earnings Per Share
As for profitability, Kayne Anderson MLP Investment Company has a trailing twelve months EPS of $2.47.
PE Ratio
Kayne Anderson MLP Investment Company has a trailing twelve months price to earnings ratio of 3.47. Meaning, the purchaser of the share is investing $3.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.06%.
Yearly Top and Bottom Value
Kayne Anderson MLP Investment Company’s stock is valued at $8.56 at 14:23 EST, way under its 52-week high of $9.66 and above its 52-week low of $7.84.
Moving Average
Kayne Anderson MLP Investment Company’s worth is above its 50-day moving average of $8.14 and higher than its 200-day moving average of $8.54.
